|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Albany Molecular Research Inc., of Albany, N.Y., opened its 28,000-square-foot Syracuse Research Center in North Syracuse, N.Y., a facility where it will conduct small-scale custom chemical synthesis to support early stage drug discovery and larger, kilogram-scale chemical development to produce drug candidates and intermediates for use in preclinical or clinical studies. Albany Molecular said the center employs 43 individuals, a number expected to rise to approximately 65 in the next few years.
BattellePharma Inc., of Columbus, Ohio, entered a second agreement with Eiffel Technologies Ltd., of Victoria, Australia, under which Eiffel will create drug ...